induction therapy with vad and vad plus cyclophosphamide ( cvad ) was followed by a 2-year rotating maintenance program with multiple antileukemic combinations , and included early intensifications with adriamycin and high-dose cytarabine ( ara-c ) and a late intensification with cyclophosphamide , carmustine ( bcnu ) , and etoposide ( vp-16 ) ( cbv ) followed by autologous bone marrow transplantation ( bmt ) .
C0007257
bcnu
C0054917
cbv